Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marsh & McLennan Companies, Inc. (MRSH) vs Symbotic Inc (SYM) Price & Performance

Marsh & McLennan Companies, Inc.Trade
Symbotic IncTrade

Price performance (Past 24H)

Key statistics

Marsh & McLennan Companies, Inc. vs Symbotic Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $176.89 (market cap $86.15B), while Symbotic Inc trades at $42.82 (market cap $5.62B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 15.3× Symbotic Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.19% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.

MRSHSYM
Market Cap
$86.15B$5.62B
Sector
FinancialsTechnology
52-Week High
$207.02$87.30
52-Week Low
$157.32$38.22
Enterprise Value
$106.83B$3.88B
Dividend Yield
2.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marsh & McLennan Companies, Inc.

Marsh & McLennan (MRSH) trades at $180.52, down 2.81% on the day, with a bullish technical signal despite recent weakness. The stock shows strong fundamentals, including consistent earnings beats, a 14.24% net income margin, and robust cash flow. Recent news highlights growth in healthcare consulting and cyber risk services, supporting revenue expansion.

Outlook remains positive with a consensus price target of $208.63, offering 15% upside. Risks include economic sensitivity and debt levels, but analyst sentiment leans bullish with 30% buy ratings. The stock presents a growth opportunity in professional services, backed by solid financials and strategic initiatives.

Symbotic Inc

SYM trades at $43.30, up 0.84% today, with a bullish technical signal from moving averages and ADX indicators. The company reported revenue of $2.25B in 2025 but posted a net loss of $16.94M, though 2026 projections show potential profitability. Analyst consensus is bullish with a $56.50 price target, representing 30% upside potential from current levels. Recent news highlights Symbotic's $22.5B backlog and strategic partnership with Stanford Robotics Center.

SYM presents growth potential with strong revenue projections and massive backlog, but faces risks from customer concentration (85% revenue from Walmart) and recent earnings misses. The stock appears undervalued with a P/E of 1,082.5, though negative EBITDA and thin margins warrant caution. Institutional interest remains positive with new investments, but insider selling and legal investigations create near-term headwinds.

Returns comparison

Trailing returns across standard periods

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH

About Symbotic Inc

Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.

Read more on SYM